| Table 1. Baseline clinical information amongst study groups | ||||
| Clinical Factor | Minimal Stimulation (CC used) N = 130 | High Dose Stimulation1 (CC not used) N = 30 | Mild Stimulation (CC not used) N = 29 | p Value |
|---|---|---|---|---|
| Age (y) at the time of the cycle | 38.4±3.7 | 36.7±4.9 | 39.1±3.1 | NS |
| BMI (kg/m2) | 25.9±5 | 26±4.9 | 24.9±3.5 | NS |
| AMH (pmol/L) | 4.9±5.7 | 5.6±2.9 | 4.8±7.1 | NS |
| Parity | 0.3±0.6 | 0.4±0.9 | 0.4±0.5 | NS |
| CC: Clomiphene citrate, BMI: Body mass index, AMH: Antimullerian hormone, NS: Not significant Values are the mean ±
standard deviation. p value ≤0.05 was considered to be statistically significant. 1: High dose stimulation used was a GnRH Antagonist Protocol |
||||